STOCK TITAN

Enovis (ENOV) director Barbara Bodem awarded 9,346 common shares in Form 4 filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Bodem Barbara W. reported acquisition or exercise transactions in this Form 4 filing.

Enovis Corp director Barbara W. Bodem received an equity award of 9,346 shares of common stock on May 19, 2026. The shares were granted at no cash cost to her, reflecting stock-based compensation rather than an open-market purchase. After this award, she directly owns 24,201 Enovis common shares.

Positive

  • None.

Negative

  • None.
Insider Bodem Barbara W.
Role null
Type Security Shares Price Value
Grant/Award Common stock, par value $0.001 9,346 $0.00 --
Holdings After Transaction: Common stock, par value $0.001 — 24,201 shares (Direct, null)
Footnotes (1)
Shares granted 9,346 shares Equity award on May 19, 2026
Grant price $0.0000 per share Recorded transaction price for the award
Shares owned after grant 24,201 shares Total direct Enovis holdings after transaction
Form 4 regulatory
"INSIDER FILING DATA (Form 4)"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
non-derivative financial
"transaction_type": "non-derivative""
transaction code "A" regulatory
"transaction_code": "A""
Grant, award, or other acquisition financial
"transaction_code_description": "Grant, award, or other acquisition""
Common stock, par value $0.001 financial
"security_title": "Common stock, par value $0.001""
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Bodem Barbara W.

(Last)(First)(Middle)
2711 CENTERVILLE ROAD
SUITE 400

(Street)
WILMINGTON DELAWARE 19808

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Enovis CORP [ ENOV ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/19/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common stock, par value $0.00105/19/2026A9,346A$0.0024,201D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
/s/ Brian P. Hanigan, attorney-in-fact05/21/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Enovis (ENOV) director Barbara Bodem report?

Barbara W. Bodem reported receiving a grant of 9,346 Enovis common shares as compensation. The award was recorded at a price of $0.0000 per share, indicating it was not an open‑market purchase but a stock-based grant increasing her direct holdings.

How many Enovis (ENOV) shares does Barbara Bodem hold after this Form 4 filing?

After the reported transaction, Barbara W. Bodem directly owns 24,201 Enovis common shares. This total reflects her previous holdings plus the 9,346-share equity award granted on May 19, 2026, as disclosed in the Form 4 insider trading report.

Was Barbara Bodem’s Enovis (ENOV) transaction a stock purchase or a grant?

The transaction was a grant, not a market purchase. The Form 4 shows transaction code “A” and describes it as a grant, award, or other acquisition, with a transaction price of $0.0000 per share, indicating stock-based compensation from Enovis to the director.

Did Barbara Bodem sell any Enovis (ENOV) shares in this Form 4 filing?

No sales were reported in this filing. The Form 4 shows one acquisition transaction coded as a grant of 9,346 common shares, with no corresponding sale or disposition entries, so her direct ownership position in Enovis increased by the full grant amount.

Is Barbara Bodem’s Enovis (ENOV) equity grant a derivative or non-derivative transaction?

The equity grant is classified as a non-derivative transaction. The Form 4 lists common stock as the security and identifies the transaction type as non-derivative, meaning Bodem received actual Enovis common shares rather than options, warrants, or other derivative instruments.